A response letter to comments on "Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016"

Eur J Cancer. 2020 Nov:140:165-166. doi: 10.1016/j.ejca.2020.09.005. Epub 2020 Oct 3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Breast Neoplasms*
  • Cohort Studies
  • Female
  • Humans
  • Receptor, ErbB-2

Substances

  • Receptor, ErbB-2